References
- Esselens CW, Malapeira J, Colome N, et al (2008). Metastasis-associated C4.4A, a GPI-anchored protein cleaved by ADAM10 and ADAM17. Biol Chem, 389, 1075-84.
- Fletcher GC, Patel S, Tyson K, et al (2003). hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan. Br J Cancer, 88, 579-85. https://doi.org/10.1038/sj.bjc.6600740
- Frank DE, Carter WG (2004). Laminin 5 deposition regulates keratinocyte polarization and persistent migration. J Cell Sci, 117, 1351-63. https://doi.org/10.1242/jcs.01003
- Fries F, Nazarenko I, Hess J, et al (2007). CEBPbeta, JunD and c-Jun contribute to the transcriptional activation of the metastasis-associated C4.4A gene. Int J Cancer, 120, 2135-47. https://doi.org/10.1002/ijc.22447
- Gao XH, Yang XQ, Wang BC, Liu SP, Wang FB (2013). Overexpression of twist and matrix metalloproteinase-9 with metastasis and prognosis in gastric cancer. Asian Pac J Cancer Prev, 14, 5055-60. https://doi.org/10.7314/APJCP.2013.14.9.5055
- Hansen LV, Gardsvoll H, Nielsen BS, et al (2004). Structural analysis and tissue localization of human C4.4A: a protein homologue of the urokinase receptor. Biochem J, 380, 845-57. https://doi.org/10.1042/BJ20031478
- Hansen LV, Laerum OD, Illemann M, Nielsen BS, Ploug M (2008). Altered expression of the urokinase receptor homologue, C4.4A, in invasive areas of human esophageal squamous cell carcinoma. Int J Cancer, 122, 734-41. https://doi.org/10.1002/ijc.23082
- Hansen LV, Skov BG, Ploug M, Pappot H (2007). Tumour cell expression of C4.4A, a structural homologue of the urokinase receptor, correlates with poor prognosis in non-small cell lung cancer. Lung Cancer, 58, 260-6. https://doi.org/10.1016/j.lungcan.2007.06.025
- Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ (2009). Gastric cancer. Lancet, 374, 477-90. https://doi.org/10.1016/S0140-6736(09)60617-6
- Jacobsen B, Ploug M (2008). The urokinase receptor and its structural homologue C4.4A in human cancer: expression, prognosis and pharmacological inhibition. Curr Med Chem, 15, 2559-73. https://doi.org/10.2174/092986708785909012
- Jemal A, Center MM, DeSantis C, Ward EM (2010). Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev, 19, 1893-907. https://doi.org/10.1158/1055-9965.EPI-10-0437
- Konishi K, Yamamoto H, Mimori K, et al (2010). Expression of C4.4A at the invasive front is a novel prognostic marker for disease recurrence of colorectal cancer. Cancer Sci, 101, 2269-77. https://doi.org/10.1111/j.1349-7006.2010.01674.x
- Li FX, Zhang RP, Liang H, et al (2013). Validity and necessity of sub-classification of N3 in the 7th UICC TNM stage of gastric cancer. Asian Pac J Cancer Prev, 14, 2091-5. https://doi.org/10.7314/APJCP.2013.14.3.2091
- Ma YY, Tao HQ (2012). Role of urokinase plasminogen activator receptor in gastric cancer: a potential therapeutic target. Cancer Biother Radiopharm, 27, 285-90. https://doi.org/10.1089/cbr.2012.1232
- Matzku S, Wenzel A, Liu S, Zoller M (1989). Antigenic differences between metastatic and nonmetastatic BSp73 rat tumor variants characterized by monoclonal antibodies. Cancer Res, 49, 1294-9.
- Mondino A, Resnati M, Blasi F (1999). Structure and function of the urokinase receptor. Thromb Haemost, 82, 19-22.
- Omejc M, Juvan R, Jelenc F, Repse S (2001). Lymph node metastases in gastric cancer: correlation between new and old UICC TNM classification. Int Surg, 86, 14-9.
- Paret C, Bourouba M, Beer A, et al (2005). Ly6 family member C4.4A binds laminins 1 and 5, associates with galectin-3 and supports cell migration. Int J Cancer, 115, 724-33. https://doi.org/10.1002/ijc.20977
- Paret C, Hildebrand D, Weitz J, et al (2007). C4.4A as a candidate marker in the diagnosis of colorectal cancer. Br J Cancer, 97, 1146-56. https://doi.org/10.1038/sj.bjc.6604012
- Rosel M, Claas C, Seiter S, Herlevsen M, Zoller M (1998). Cloning and functional characterization of a new phosphatidyl-inositol anchored molecule of a metastasizing rat pancreatic tumor. Oncogene, 17, 1989-2002. https://doi.org/10.1038/sj.onc.1202079
- Sadowski T, Dietrich S, Koschinsky F, et al (2005). Matrix metalloproteinase 19 processes the laminin 5 gamma 2 chain and induces epithelial cell migration. Cell Mol Life Sci, 62, 870-80. https://doi.org/10.1007/s00018-005-4478-8
- Seiter S, Stassar M, Rappl G, et al (2001). Upregulation of C4.4A expression during progression of melanoma. J Invest Dermatol, 116, 344-7. https://doi.org/10.1046/j.1523-1747.2001.01230.x
- Smith BA, Kennedy WJ, Harnden P, et al (2001). Identification of genes involved in human urothelial cell-matrix interactions: implications for the progression pathways of malignant urothelium. Cancer Res, 61, 1678-85.
- Udayakumar TS, Chen ML, Bair EL, et al (2003). Membrane type-1-matrix metalloproteinase expressed by prostate carcinoma cells cleaves human laminin-5 beta3 chain and induces cell migration. Cancer Res, 63, 2292-9.
- Wang J, Yu JC, Kang WM, Ma ZQ (2012). Treatment strategy for early gastric cancer. Surg Oncol, 21, 119-23. https://doi.org/10.1016/j.suronc.2010.12.004
- Wurfel J, Seiter S, Stassar M, et al (2001). Cloning of the human homologue of the metastasis-associated rat C4.4A. Gene, 262, 35-41. https://doi.org/10.1016/S0378-1119(00)00515-1
- Yamamoto H, Oshiro R, Ohtsuka M, et al (2013). Distinct expression of C4.4A in colorectal cancer detected by different antibodies. Int J Oncol, 42, 197-201. https://doi.org/10.3892/ijo.2012.1714
Cited by
- Expression of the Ly6/uPAR-Domain Proteins C4.4A and Haldisin in Non-Invasive and Invasive Skin Lesions vol.63, pp.2, 2015, https://doi.org/10.1369/0022155414563107